Overview
Recruitment of participants to the study takes place at the urological department at Zealand University Hospital, Roskilde, Feb. 2018-April 2018. 10 people with diagnosis of renal cancer should be recruited in phases 1. Subsequently, biological materials from 100 patients with kidney cancer will be used from the national Biobank. In phase 3, 10 patients will be recruited for the final gene test.
Eligibility
Inclusion Criteria:
- Patients who have been diagnosed with kidney cancer.
Exclusion Criteria:
- Patients without signs of malignancy at final histology report.
- Incapacitated patients.